These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32677765)

  • 1. Monitoring the performance of foot-and-mouth disease vaccines prepared against local strains in the face of antigenic evolution in the field.
    Tuncer-Göktuna P; Çokçalışkan C; Arslan A; Taşçene N; Uzun EA; Gündüzalp C; Balcı GN; Kara O; Gülyaz V
    Transbound Emerg Dis; 2021 Mar; 68(2):648-655. PubMed ID: 32677765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Vaccine Based on the A/ASIA/G-VII Lineage of Foot-and-Mouth Disease Virus Offers Low Levels of Protection against Circulating Viruses from the A/ASIA/Iran-05 lineage.
    Singanallur NB; Eblé PL; Ludi AB; Statham B; Bin-Tarif A; King DP; Dekker A; Vosloo W
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of combined effect of amino acid substitutions within G-H and B-C loops of VP1 conferring serological heterogeneity in foot-and-mouth disease virus serotype A.
    Islam MR; Rahman MS; Amin MA; Alam ASMRU; Siddique MA; Sultana M; Hossain MA
    Transbound Emerg Dis; 2021 Mar; 68(2):375-384. PubMed ID: 32543041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage.
    Lyons NA; Ludi AB; Wilsden G; Hamblin P; Qasim IA; Gubbins S; King DP
    Vaccine; 2017 Dec; 35(49 Pt B):6850-6857. PubMed ID: 29108665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
    Waters R; Ludi AB; Fowler VL; Wilsden G; Browning C; Gubbins S; Statham B; Bin-Tarif A; Mioulet V; King DJ; Colenutt C; Brown E; Hudelet P; King DP
    Vaccine; 2018 Mar; 36(14):1901-1907. PubMed ID: 29506922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Basis of Antigenic Drift in Serotype O Foot-and-Mouth Disease Viruses (2013-2018) from Southeast Asia.
    Upadhyaya S; Mahapatra M; Mioulet V; Parida S
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
    Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
    Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India.
    Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK
    Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of antigenic variants with in serotype A foot and mouth disease virus in India and evaluation of a new vaccine candidate panel.
    Rudreshappa AG; Sanyal A; Mohapatra JK; Subramaniam S; De A; Das B; Singanallur NB; Jangam AK; Muthukrishnan M; Villuppanoor SA; Pattnaik B
    Vet Microbiol; 2012 Aug; 158(3-4):405-9. PubMed ID: 22445197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2014 Apr; 32(16):1848-55. PubMed ID: 24530150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SAT2 foot-and-mouth disease 2013/2014 outbreak viruses at the wildlife-livestock interface in South Africa.
    Blignaut B; van Heerden J; Reininghaus B; Fosgate GT; Heath L
    Transbound Emerg Dis; 2020 Jul; 67(4):1595-1606. PubMed ID: 31984622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain.
    Lloyd-Jones K; Mahapatra M; Upadhyaya S; Paton DJ; Babu A; Hutchings G; Parida S
    Vaccine; 2017 Dec; 35(49 Pt B):6842-6849. PubMed ID: 29102329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of antigenic and genetic characteristics of foot-and-mouth disease virus serotype A circulating in Thailand, 2007-2019.
    Seeyo KB; Nishi T; Kawaguchi R; Ungvanijban S; Udon R; Fukai K; Yamakawa M; Rukkwamsuk T
    Virus Res; 2020 Dec; 290():198166. PubMed ID: 32961212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence Analysis of Egyptian Foot-and-Mouth Disease Virus Field and Vaccine Strains: Intertypic Recombination and Evidence for Accidental Release of Virulent Virus.
    Abd El Rahman S; Hoffmann B; Karam R; El-Beskawy M; Hamed MF; Forth LF; Höper D; Eschbaumer M
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
    Mahapatra M; Upadhyaya S; Aviso S; Babu A; Hutchings G; Parida S
    Vaccine; 2017 Dec; 35(51):7147-7153. PubMed ID: 29157957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of doubled dose administration of foot-and-mouth disease vaccine against heterologous virus infection in cattle.
    Kawaguchi R; Nishi T; Fukai K; Ikezawa M; Kokuho T; Morioka K
    J Vet Med Sci; 2024 Jul; 86(7):777-786. PubMed ID: 38719616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.